Tick-Transmitted Diseases in Dogs: Pathogens, Clinical Syndromes, and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Tick-transmitted pathogens in dogs include bacteria (_Borrelia burgdorferi_, _Ehrlichia canis_, _Anaplasma phagocytophilum_, _Anaplasma platys_) and protozoa (_Babesia_ spp., _Hepatozoon canis_), each with specific tick vectors and target cells, leading to diverse clinical syndromes from lameness and fever to severe anemia and pancytopenia.
• Diagnosis necessitates a multi-modal approach combining clinical signs, hematologic evaluation (e.g., thrombocytopenia, anemia), serology (IFA, ELISA for antibodies), and direct pathogen detection via blood smear microscopy or highly sensitive molecular methods like PCR for definitive identification and co-infection detection.
• Treatment protocols are pathogen-specific: doxycycline is the primary antibiotic for rickettsial and spirochetal infections (_Ehrlichia_, _Anaplasma_, _Borrelia_), while antiprotozoal agents like imidocarb dipropionate or atovaquone/azithromycin are used for _Babesia_ infections.
• Prevention is paramount and relies on consistent application of acaricides and repellents, with isoxazoline compounds offering potent systemic efficacy, alongside environmental management to reduce tick habitats.
• Clinical manifestations vary significantly, with Lyme disease presenting as intermittent lameness, monocytic ehrlichiosis progressing through acute, subclinical, and chronic phases with potential for immunosuppression, and babesiosis causing hemolytic anemia.

Introduction

Tick-transmitted diseases represent a major category of vector-borne infections in dogs worldwide. The geographic expansion of tick populations, driven by climatic and ecological changes, has increased the exposure risk for companion animals across temperate, tropical, and subtropical regions [<a href="#ref-1">1</a>]. These pathogens belong to diverse taxonomic groups including bacteria, rickettsiae, protozoa, and in some cases viruses, each with distinct mechanisms of host invasion, immune evasion, and pathology [<a href="#ref-2">2</a>]. Understanding the interplay between tick biology, pathogen transmission dynamics, and canine host responses is essential for accurate diagnosis, effective treatment, and rational prevention [<a href="#ref-3">3</a>].

This article provides a detailed review of the principal tick-transmitted pathogens affecting dogs, their clinical syndromes, diagnostic methodologies with emphasis on molecular and biophysical principles, therapeutic protocols, and integrated control strategies. The discussion does not extend to human clinical disease unless direct comparative host-range parallels inform veterinary practice [<a href="#ref-4">4</a>].

Etiology of Canine Tick-Transmitted Diseases

Tick-transmitted diseases in dogs are caused by obligate intracellular bacteria, extracellular spirochetes, intraerythrocytic protozoa, and occasionally viruses [<a href="#ref-5">5</a>]. The major pathogens are listed in Table 1 along with their vector species and primary target cells.

Table 1: Principal Tick-Transmitted Pathogens of Dogs

Transmission occurs primarily during tick feeding, with spirochetes and rickettsiae requiring a feeding period of 24 to 48 hours before effective inoculation [<a href="#ref-6">6</a>]. _Hepatozoon canis_ is unique in requiring ingestion of the infected tick for transmission [<a href="#ref-7">7</a>].

Clinical Syndromes

Lyme Disease (Borreliosis)

Lyme disease is caused by _Borrelia burgdorferi_ sensu stricto and is transmitted by _Ixodes_ species ticks [<a href="#ref-8">8</a>]. The spirochete colonizes the extracellular matrix of connective tissues after inoculation, disseminating primarily through the dermis and later to joints, kidneys, and nervous tissue [<a href="#ref-9">9</a>]. Clinical signs in dogs include intermittent lameness due to polyarthritis, fever, lethargy, and lymphadenomegaly [<a href="#ref-10">10</a>]. A small proportion of dogs develop a protein-losing nephropathy, known as Lyme nephritis, which carries a poor prognosis [<a href="#ref-11">11</a>]. The pathophysiological basis of this nephropathy is immune complex deposition in the glomerular basement membrane, leading to membranoproliferative glomerulonephritis [<a href="#ref-12">12</a>].

Monocytic Ehrlichiosis

_Ehrlichia canis_ is the most important species causing monocytic ehrlichiosis in dogs [<a href="#ref-13">13</a>]. The bacterium infects monocytes and macrophages, leading to systemic dissemination. The disease evolves through three phases: acute, subclinical, and chronic [<a href="#ref-14">14</a>]. The acute phase is characterized by fever, thrombocytopenia, and mild anemia. The subclinical phase may persist for months to years, during which the dog appears healthy but remains ehrlichemic [<a href="#ref-15">15</a>]. Chronic ehrlichiosis is a severe wasting disease with pancytopenia, hemorrhagic diathesis, and secondary infections due to immunosuppression [<a href="#ref-16">16</a>]. Thrombocytopenia is a hallmark finding and results from immune-mediated destruction and platelet consumption [<a href="#ref-17">17</a>].

Granulocytic Anaplasmosis

_Anaplasma phagocytophilum_ infects neutrophils and causes acute febrile illness with polyarthritis, lameness, and thrombocytopenia [<a href="#ref-18">18</a>]. Clinical signs are often similar to those of Lyme disease in endemic areas where both pathogens share the same tick vector [<a href="#ref-19">19</a>]. Co-infection with _Borrelia burgdorferi_ can exacerbate clinical severity [<a href="#ref-20">20</a>].

Thrombocytotropic Anaplasmosis

_Anaplasma platys_ is a platelet-specific rickettsia transmitted by _Rhipicephalus sanguineus_ [<a href="#ref-21">21</a>]. Infection results in cyclical thrombocytopenia with a 10- to 14-day periodicity [<a href="#ref-22">22</a>]. The platelet count nadirs are often severe but clinical signs are usually mild, consisting of petechiae, epistaxis, and prolonged bleeding [<a href="#ref-23">23</a>].

Canine Babesiosis

Babesiosis is caused by intraerythrocytic protozoan parasites of the genus _Babesia_. Large forms (_Babesia canis_ sensu stricto) cause acute hemolytic anemia with fever, hemoglobinuria, and icterus [<a href="#ref-24">24</a>]. Small forms (_Babesia gibsoni_, _Babesia vulpes_) tend to be more chronic and are associated with severe anemia and splenomegaly [<a href="#ref-25">25</a>]. Pathophysiology involves erythrocyte lysis, oxidative damage, and immune-mediated hemolysis triggered by the parasite's metabolic byproducts [<a href="#ref-26">26</a>].

Hepatozoonosis

_Hepatozoon canis_ infection occurs following ingestion of infected _Rhipicephalus sanguineus_ ticks [<a href="#ref-27">27</a>]. The parasite undergoes sexual reproduction in the tick gut and sporogony in the hemocoel; after ingestion, sporozoites invade leukocytes and form intramonocytic gametocytes [<a href="#ref-28">28</a>]. Clinical signs include fever, myositis, periosteal bone proliferation, and extreme leukocytosis [<a href="#ref-29">29</a>].

Diagnostic Approaches

Accurate diagnosis of tick-transmitted diseases in dogs relies on a combination of clinical suspicion, hematologic and biochemical profiling, serology, and direct pathogen detection via microscopy or molecular methods [<a href="#ref-30">30</a>].

Hematology and Cytology

Complete blood counts are essential. Automated impedance analyzers can quantify thrombocytopenia, anemia, and leukocyte abnormalities [<a href="#ref-31">31</a>]. Examination of stained blood smears (Giemsa or Diff-Quik) allows direct visualization of _Babesia_ merozoites within erythrocytes, _Ehrlichia_ morulae in monocytes, _Anaplasma phagocytophilum_ morulae in neutrophils, and _Anaplasma platys_ inclusion bodies in platelets [<a href="#ref-32">32</a>]. Sensitivity of blood smear examination is low (20%-50%) compared to molecular methods [<a href="#ref-33">33</a>].

Serology

Indirect immunofluorescence assays (IFAs) and commercial ELISA kits detect antibodies against _E. canis_, _A. phagocytophilum_, _B. burgdorferi_, and _Babesia_ species [<a href="#ref-34">34</a>]. Seroconversion occurs 2 to 4 weeks post infection. The presence of antibodies indicates exposure but does not confirm active infection, as seropositivity can persist for months after clearance [<a href="#ref-35">35</a>]. Point-of-care ELISA tests that detect both antibodies and antigens (e.g., for _Dirofilaria immitis_ antigen in context of "dog heartworm and tick medicine") are widely used in clinical practice [<a href="#ref-36">36</a>].

Molecular Diagnostics

Polymerase chain reaction (PCR) targeting species-specific gene sequences provides high sensitivity and specificity for pathogen detection [<a href="#ref-37">37</a>]. For _E. canis_, the p30/omp-1 gene family is often targeted [<a href="#ref-38">38</a>]. For _Anaplasma_ spp., the 16S rRNA gene or the major surface protein (msp2) is used [<a href="#ref-39">39</a>]. _Babesia_ detection typically targets the 18S rRNA gene [<a href="#ref-40">40</a>]. PCR is particularly valuable in the early acute phase before seroconversion and for identifying co-infections [<a href="#ref-41">41</a>].

Quantitative PCR (qPCR) allows pathogen load estimation, which can be useful for monitoring treatment response [<a href="#ref-42">42</a>].

flowchart TD
 A["Clinical suspicion based on history and signs"] --> B{"Is thrombocytopenia present?"}
 B -->|"Yes"| C["Examine blood smear for morulae/inclusions"]
 B -->|"No"| D["Consider non-rickettsial causes"]
 C --> E{"Morulae seen?"}
 E -->|"Yes"| F["Diagnosis of ehrlichiosis or anaplasmosis supported"]
 E -->|"No"| G["Perform serology and/or PCR"]
 G --> H{"Antibody positive?"}
 H -->|"Yes"| I["Confirm with PCR if active infection suspected"]
 H -->|"No"| J["Consider alternative pathogen or early infection"]
 I --> K["Treat based on pathogen identification"]
 K --> L["Monitor hematologic recovery"]

Treatment

Rickettsial and Spirochetal Infections

Doxycycline is the cornerstone of treatment for _E. canis_, _A. phagocytophilum_, and _A. platys_ infections [<a href="#ref-43">43</a>]. The recommended dose is 5 mg/kg per os every 12 hours or 10 mg/kg every 24 hours for 28 days for ehrlichiosis [<a href="#ref-44">44</a>]. For anaplasmosis, a 14- to 21-day course is usually sufficient [<a href="#ref-45">45</a>]. _Borrelia burgdorferi_ infection is treated with doxycycline at 10 mg/kg per os every 24 hours for 30 days [<a href="#ref-46">46</a>]. Tetracyclines are contraindicated in growing puppies due to enamel hypoplasia; in such cases, alternative agents like amoxicillin or enrofloxacin may be considered, though they are less effective [<a href="#ref-47">47</a>].

Supportive care for immune-mediated complications includes immunosuppressive doses of glucocorticoids when severe thrombocytopenia or hemolytic anemia is present [<a href="#ref-48">48</a>].

Protozoal Infections

Treatment of canine babesiosis depends on the species. _Babesia canis_ and _B. vogeli_ are typically treated with imidocarb dipropionate at 5-6.6 mg/kg intramuscularly or subcutaneously, repeated once after 14 days [<a href="#ref-49">49</a>]. For _Babesia gibsoni_, atovaquone (13.5 mg/kg per os every 8 hours) combined with azithromycin (10 mg/kg per os every 24 hours) has shown efficacy, though resistance can develop [<a href="#ref-50">50</a>]. Blood transfusion is indicated for severe anemia with packed cell volume below 15% to 20% [<a href="#ref-51">51</a>].

_Hepatozoon canis_ infection is treated with imidocarb or toltrazuril, but cure is rarely achieved because the parasite persists in tissues [<a href="#ref-52">52</a>].

Prevention and Control

Prevention of tick-transmitted diseases in dogs relies on reducing tick exposure and using chemoprophylaxis [<a href="#ref-53">53</a>]. The concept of "dog tick transmitted diseases" management is intrinsically linked to routine use of acaricides and repellents.

Tick Control Products

Effective tick prevention requires products with repellent and/or acaricidal activity. Isoxazoline compounds (such as fluralaner, afoxolaner, and sarolaner) provide potent systemic activity against multiple tick species with rapid onset of kill. These are available as oral formulations and are often combined with heartworm preventive drugs in a single product, addressing "dog heartworm and tick medicine" as a combination prophylaxis. Topical pyrethroids, collars containing imidacloprid and flumethrin, and permethrin-based formulations also provide residual repellency.

Environmental Management

Reducing tick habitat in the yard by maintaining short grass, removing leaf litter, and creating barriers of wood chips or gravel can decrease tick populations. Tick tubes and acaricide treatments for premises are adjunct strategies.

Vaccination

A recombinant OspA vaccine against _Borrelia burgdorferi_ is available for dogs in endemic areas. Vaccination does not prevent infection but reduces spirochete clearance and clinical disease severity. No vaccines exist for other tick-transmitted pathogens of dogs.

Conclusions

Tick-transmitted diseases in dogs pose significant clinical challenges due to their diverse pathogen biology, overlapping clinical presentations, and the potential for co-infections. Diagnosis must integrate clinical, hematologic, serologic, and molecular modalities. Treatment is largely directed at the specific pathogen with doxycycline for rickettsial and spirochetal infections and antiprotozoals for babesiosis. Prevention through rigorous tick control and combination heartworm and tick products remains the most effective strategy. Ongoing surveillance of tick-borne pathogen prevalence and resistance patterns is necessary to refine clinical protocols.

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention

References